Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-25-021055
Filing Date
2025-09-02
Accepted
2025-09-02 10:12:24
Documents
2
Period of Report
2025-08-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 1465
2 POWER OF ATTORNEY (PUBLIC): POA doc1.txt EX-24 3924
  Complete submission text file 0001127602-25-021055.txt   6781
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Issuer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 100 FIFTH STREET 3RD FLOOR WALTHAM MA 02451
Business Address
MELTZER LESLIE (Reporting) CIK: 0002084030 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38276 | Film No.: 251283430